11 Brain Cancer Clinical Trials in Atlanta, GA (2026)

Q: How do I join a clinical trial in Atlanta?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you.

Recruiting Brain Cancer Studies in Atlanta

NCT05902169Recruiting

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

The brain is protected from any toxic or inflammatory molecule by the blood-brain barrier (BBB). This physical barrier is located at the level of the blood vessel walls. Because of these barrier prope...

Atlanta, GAPHASE3560 participantsCarThera

View Study Details

NCT04732065Recruiting

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

This phase I trial studies the effects and best dose of ONC206 alone or in combination with radiation therapy in treating patients with diffuse midline gliomas that is newly diagnosed or has come back...

Atlanta, GAPHASE1208 participantsSabine Mueller, MD, PhD

View Study Details

NCT06132685Recruiting

Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

This phase II trial tests the effect of decreasing (tapering) doses of dexamethasone on steroid side effects in patients after surgery to remove (craniotomy) a brain tumor. Steroids are the gold stand...

Atlanta, GAPHASE2200 participantsEmory University

View Study Details

NCT07326566Recruiting

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

The purpose of this study is to see if combining silevertinib with temozolomide after surgery and radiotherapy helps treat newly diagnosed glioblastoma (GBM) better than using temozolomide alone in th...

Atlanta, GAPHASE2162 participantsBlack Diamond Therapeutics, Inc.

View Study Details

NCT06319027Recruiting

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

This phase II trial studies whether different imaging techniques can provide additional and more accurate information than the usual approach for assessing the activity of tumors in patients with newl...

Atlanta, GAPHASE2100 participantsECOG-ACRIN Cancer Research Group

View Study Details

NCT07680439Recruiting

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

This study will evaluate BCB-276, an investigational B7-H3-targeted Chimeric Antigen Receptor (CAR) T cell therapy, in children and young adults with diffuse intrinsic pontine glioma (DIPG). DIPG is a...

Atlanta, GAPHASE275 participantsBrainChild Bio, Inc

View Study Details

NCT06838676Recruiting

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

This is a Phase II open-label study to investigate the safety and efficacy of ACT001 in patients with DIPG and H3K27-altered HGG....

Atlanta, GAPHASE260 participantsNationwide Children's Hospital

View Study Details

NCT04908709Recruiting

Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors

This trial studies how well spectroscopic magnetic resonance imaging (MRI) guided proton therapy works in assessing metabolic change in pediatric patients with brain tumors. The non-invasive imaging, ...

Atlanta, GANA25 participantsEmory University

View Study Details

NCT04590664Recruiting

Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma

This phase I/II trial studies the side effects and best dose of Visudyne (liposomal verteporfin) and to see how well it works in treating patients with high grade EGFR-mutated glioblastoma that has co...

Atlanta, GAPHASE124 participantsEmory University

View Study Details

NCT06624371Recruiting

Atovaquone Combined With Radiation in Children With Malignant Brain Tumors

The goal of this interventional study is to Assess the safety and tolerability of atovaquone in combination with standard radiation therapy (RT) for the treatment of pediatric patients with newly diag...

Atlanta, GAPHASE118 participantsEmory University

View Study Details

NCT05310448Recruiting

Tumor Treating Fields for the Treatment of Brainstem Gliomas

This clinical trial tests the safety and side effects of tumor treating fields in treating patients with gliomas located in the brainstem. Optune is a wearable, portable, treatment that creates low-in...

Atlanta, GANA10 participantsEmory University

View Study Details

About Brain Cancer Clinical Trials in Atlanta

Brain cancer includes tumors that originate in the brain (primary) or spread from other areas (metastatic). Glioblastoma (GBM) is the most common and aggressive primary brain tumor. Treatment typically combines surgery, radiation, and chemotherapy, with immunotherapy trials underway.

There are currently 11 brain cancer clinical trials recruiting participants in Atlanta, GA. These studies are seeking a combined 1,442 participants. Research is being sponsored by CarThera, Sabine Mueller, MD, PhD, Emory University and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Brain Cancer Clinical Trials in Atlanta — FAQ

Are there brain cancer clinical trials in Atlanta?

Yes, there are 11 brain cancer clinical trials currently recruiting in Atlanta, GA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Atlanta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.

Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.

What brain cancer treatments are being tested?

The 11 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for brain cancer.

Data updated September 7, 2026 from ClinicalTrials.gov